BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33074327)

  • 1. Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial.
    Rooks D; Swan T; Goswami B; Filosa LA; Bunte O; Panchaud N; Coleman LA; Miller RR; Garcia Garayoa E; Praestgaard J; Perry RG; Recknor C; Fogarty CM; Arai H; Chen LK; Hashimoto J; Chung YS; Vissing J; Laurent D; Petricoul O; Hemsley S; Lach-Trifilieff E; Papanicolaou DA; Roubenoff R
    JAMA Netw Open; 2020 Oct; 3(10):e2020836. PubMed ID: 33074327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study.
    Rooks D; Praestgaard J; Hariry S; Laurent D; Petricoul O; Perry RG; Lach-Trifilieff E; Roubenoff R
    J Am Geriatr Soc; 2017 Sep; 65(9):1988-1995. PubMed ID: 28653345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial.
    Hofbauer LC; Witvrouw R; Varga Z; Shiota N; Cremer M; Tanko LB; Rooks D; Auberson LZ; Arkuszewski M; Fretault N; Schubert-Tennigkeit AA; Papanicolaou DA; Recknor C
    Lancet Healthy Longev; 2021 May; 2(5):e263-e274. PubMed ID: 36098133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial.
    Heymsfield SB; Coleman LA; Miller R; Rooks DS; Laurent D; Petricoul O; Praestgaard J; Swan T; Wade T; Perry RG; Goodpaster BH; Roubenoff R
    JAMA Netw Open; 2021 Jan; 4(1):e2033457. PubMed ID: 33439265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Sarcopenia Among Community-Dwelling At-Risk Frail Adults Aged 65 Years and Older Who Received Multidomain Lifestyle Interventions: A Secondary Analysis of a Randomized Clinical Trial.
    Lu Y; Niti M; Yap KB; Tan CTY; Zin Nyunt MS; Feng L; Tan BY; Chan G; Khoo SA; Chan SM; Yap P; Larbi A; Ng TP
    JAMA Netw Open; 2019 Oct; 2(10):e1913346. PubMed ID: 31617926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise and Nutrition for Healthy AgeiNg (ENHANce) project - effects and mechanisms of action of combined anabolic interventions to improve physical functioning in sarcopenic older adults: study protocol of a triple blinded, randomized controlled trial.
    Dedeyne L; Dupont J; Koppo K; Verschueren S; Tournoy J; Gielen E
    BMC Geriatr; 2020 Dec; 20(1):532. PubMed ID: 33302879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort.
    Rooks D; Petricoul O; Praestgaard J; Bartlett M; Laurent D; Roubenoff R
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1525-1534. PubMed ID: 33264516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial.
    ; Achison M; Adamson S; Akpan A; Aspray T; Avenell A; Band MM; Bashir T; Burton LA; Cvoro V; Donnan PT; Duncan GW; George J; Gordon AL; Gregson CL; Hapca A; Henderson E; Hume C; Jackson TA; Kemp P; Kerr S; Kilgour A; Lyell V; Masud T; McKenzie A; McKenzie E; Patel H; Pilvinyte K; Roberts HC; Rossios C; Sayer AA; Smith KT; Soiza RL; Steves CJ; Struthers AD; Sumukadas D; Tiwari D; Whitney J; Witham MD
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):858-871. PubMed ID: 35174663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
    Amato AA; Hanna MG; Machado PM; Badrising UA; Chinoy H; Benveniste O; Karanam AK; Wu M; Tankó LB; Schubert-Tennigkeit AA; Papanicolaou DA; Lloyd TE; Needham M; Liang C; Reardon KA; de Visser M; Ascherman DP; Barohn RJ; Dimachkie MM; Miller JAL; Kissel JT; Oskarsson B; Joyce NC; Van den Bergh P; Baets J; De Bleecker JL; Karam C; David WS; Mirabella M; Nations SP; Jung HH; Pegoraro E; Maggi L; Rodolico C; Filosto M; Shaibani AI; Sivakumar K; Goyal NA; Mori-Yoshimura M; Yamashita S; Suzuki N; Aoki M; Katsuno M; Morihata H; Murata K; Nodera H; Nishino I; Romano CD; Williams VSL; Vissing J; Zhang Auberson L;
    Neurology; 2021 Mar; 96(12):e1595-e1607. PubMed ID: 33597289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porvoo sarcopenia and nutrition trial: effects of protein supplementation on functional performance in home-dwelling sarcopenic older people - study protocol for a randomized controlled trial.
    Bjorkman MP; Suominen MH; Pitkälä KH; Finne-Soveri HU; Tilvis RS
    Trials; 2013 Nov; 14():387. PubMed ID: 24225081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a Timing and Coordination Group Exercise Program to Improve Mobility in Community-Dwelling Older Adults: A Randomized Clinical Trial.
    Brach JS; Perera S; Gilmore S; VanSwearingen JM; Brodine D; Nadkarni NK; Ricci E
    JAMA Intern Med; 2017 Oct; 177(10):1437-1444. PubMed ID: 28806436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.
    Hanna MG; Badrising UA; Benveniste O; Lloyd TE; Needham M; Chinoy H; Aoki M; Machado PM; Liang C; Reardon KA; de Visser M; Ascherman DP; Barohn RJ; Dimachkie MM; Miller JAL; Kissel JT; Oskarsson B; Joyce NC; Van den Bergh P; Baets J; De Bleecker JL; Karam C; David WS; Mirabella M; Nations SP; Jung HH; Pegoraro E; Maggi L; Rodolico C; Filosto M; Shaibani AI; Sivakumar K; Goyal NA; Mori-Yoshimura M; Yamashita S; Suzuki N; Katsuno M; Murata K; Nodera H; Nishino I; Romano CD; Williams VSL; Vissing J; Auberson LZ; Wu M; de Vera A; Papanicolaou DA; Amato AA;
    Lancet Neurol; 2019 Sep; 18(9):834-844. PubMed ID: 31397289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health maintenance through home-based interventions for community-dwelling older people with sarcopenia during and after the COVID-19 pandemic: A systematic review and meta-analysis.
    Li ML; Kor PP; Sui YF; Liu JY
    Exp Gerontol; 2023 Apr; 174():112128. PubMed ID: 36804363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: a randomized controlled trial.
    Zhu LY; Chan R; Kwok T; Cheng KC; Ha A; Woo J
    Age Ageing; 2019 Mar; 48(2):220-228. PubMed ID: 30462162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Home-Based Exercise Program on Subsequent Falls Among Community-Dwelling High-Risk Older Adults After a Fall: A Randomized Clinical Trial.
    Liu-Ambrose T; Davis JC; Best JR; Dian L; Madden K; Cook W; Hsu CL; Khan KM
    JAMA; 2019 Jun; 321(21):2092-2100. PubMed ID: 31162569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial.
    Polkey MI; Praestgaard J; Berwick A; Franssen FME; Singh D; Steiner MC; Casaburi R; Tillmann HC; Lach-Trifilieff E; Roubenoff R; Rooks DS
    Am J Respir Crit Care Med; 2019 Feb; 199(3):313-320. PubMed ID: 30095981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.
    Becker C; Lord SR; Studenski SA; Warden SJ; Fielding RA; Recknor CP; Hochberg MC; Ferrari SL; Blain H; Binder EF; Rolland Y; Poiraudeau S; Benson CT; Myers SL; Hu L; Ahmad QI; Pacuch KR; Gomez EV; Benichou O;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):948-57. PubMed ID: 26516121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high whey protein, vitamin D and E supplement preserves muscle mass, strength, and quality of life in sarcopenic older adults: A double-blind randomized controlled trial.
    Bo Y; Liu C; Ji Z; Yang R; An Q; Zhang X; You J; Duan D; Sun Y; Zhu Y; Cui H; Lu Q
    Clin Nutr; 2019 Feb; 38(1):159-164. PubMed ID: 29395372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).
    Bernabei R; Landi F; Calvani R; Cesari M; Del Signore S; Anker SD; Bejuit R; Bordes P; Cherubini A; Cruz-Jentoft AJ; Di Bari M; Friede T; Gorostiaga Ayestarán C; Goyeau H; Jónsson PV; Kashiwa M; Lattanzio F; Maggio M; Mariotti L; Miller RR; Rodriguez-Mañas L; Roller-Wirnsberger R; Rýznarová I; Scholpp J; Schols AMWJ; Sieber CC; Sinclair AJ; Skalska A; Strandberg T; Tchalla A; Topinková E; Tosato M; Vellas B; von Haehling S; Pahor M; Roubenoff R; Marzetti E;
    BMJ; 2022 May; 377():e068788. PubMed ID: 35545258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly.
    Nilsson MI; Mikhail A; Lan L; Di Carlo A; Hamilton B; Barnard K; Hettinga BP; Hatcher E; Tarnopolsky MG; Nederveen JP; Bujak AL; May L; Tarnopolsky MA
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32785021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.